Turkish Journal of Nephrology
Original Article

The Frequency Of Metabolic Syndrome in Patients on Continuous Ambulatory Peritoneal Dialysis and the Association of Developing Metabolic Syndrome Wıth Dialysis Duration

1.

Dicle Üniversitesi Tıp Fakültesi, Nefroloji Bilim Dalı, Diyarbakır, Türkiye

2.

Dicle Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Diyarbakır, Türkiye

Turkish J Nephrol 2011; 20: 168-172
DOI: 10.5262/tndt.2011.1002.09
Read: 984 Downloads: 631 Published: 07 February 2019

OBJECTIVE: To evaluate the characteristics of patients with metabolic syndrome, and the association of developing MS with peritoneal dialysis duration among patients undergoing continuous ambulatory peritoneal dialysis.

MATERIAL and METHODS: Fifty-eight nondiabetic CAPD patients were evaluated. Biochemical parameters, blood pressure, length, weight, waist circumference, and body mass indexes were recorded. MS was determined using NCP-ATP III criteria. The patients were divided into 3 groups according to dialysis duration (Group 1: ≤60 months, Group 2: 61-120 months, Group 3: ≥121 months) and the frequency of MS was compared.

RESULTS: Twenty-four of 58 patients were male, and MS was present in 22 (37.9%) patients. 14 (82.4%) of 22 patients with MS were female, (p=0.544). There was a statistically significant difference between patients with and without MS regarding age, BMI, waist circumference, PD duration, and triglyceride levels (p<0.05). 55% (n=32) of the patients were in group 1, 34.5% (n=20) in group 2, and 10.5% (n=6) in group 3 (p=0.092). The frequency of MS decreased with prolongation of dialysis duration (50% in group 1, 20% in group 2, and 33,3% in group 3) (p<0.001).

CONCLUSION: The frequency of MS among our CAPD patients was 37.9% and it decreased with prolongation of dialysis duration. This result may suggest that alterations in metabolic state, and abandoning glucose-based PD solutions may improve MS criteria.

Files
EISSN 2667-4440